- Analysis of records for more than 63 million Medicare enrollees from 2000 to 2016 finds long-term exposure to air pollution had a significant impact on the number of people hospitalized for cardiac and respiratory conditions.
- Researchers examined three components of air pollution: fine particulate matter, nitrogen dioxide and ozone. Even levels lower than national standards affected heart and respiratory illnesses.
- Each unit increase in the level of particulate matter, nitrogen dioxide and ozone was associated with thousands of hospital admissions per year, indicating air pollution should be considered a risk factor for heart disease and lung disease.
Embargoed until 4 a.m. CT/5 a.m. ET Monday, Feb. 22, 2021
(NewMediaWire) – February 22, 2021 – DALLAS – Exposure to what is considered low levels of air pollution over a long period of time can increase the risk of heart attack, stroke, atrial fibrillation and pneumonia among people ages 65 and older, according to new research published today in the American Heart Association’s flagship journal Circulation.
Air pollution can cause harm to the cardiovascular and respiratory systems due to its effect on inflammation in the heart and throughout the body. Newer studies on the impact of air pollution on health are focused on understanding the potential harm caused by long-term exposure and are researching the effects of multiple air pollutants simultaneously. Research on air pollution is critical to informing recommendations for national environmental and health guidelines.
“People should be conscious of the air quality in the region where they live to avoid harmful exposure over long periods of time, if possible,” said Mahdieh Danesh Yazdi, Pharm.D., M.P.H., Ph.D., a post-doctoral research fellow at the Harvard T.H. Chan School of Public Health and lead author of the study. “Since our study found harmful effects at levels below current U.S. standards, air pollution should be considered as a risk factor for cardiovascular and respiratory disease by clinicians, and policy makers should reconsider current standards for air pollutants.”
Researchers examined hospitalization records for more than 63 million Medicare enrollees in the contiguous Unites States from 2000 to 2016 to assess how long-term exposure to air pollution impacts hospital admissions for specific cardiovascular and respiratory issues. The study measured three components of air pollution: fine particulate matter (PM2.5), nitrogen dioxide (NO2) and ozone (O3). Using hundreds of predictors, including meteorological values, satellite measurements and land use to estimate daily levels of pollutants, researchers calculated the study participants’ exposure to the pollutants based upon their residential zip code. Additional analysis included the impact of the average yearly amounts of each of the pollutants on hospitalization rates for non-fatal heart attacks, ischemic strokes, atrial fibrillation and flutter, and pneumonia.
Statistical analyses found thousands of hospital admissions were attributable to air pollution per year. Specifically:
- The risks for heart attacks, strokes, atrial fibrillation and flutter, and pneumonia were associated with long-term exposure to particulate matter.
- Data also showed there were surges in hospital admissions for all of the health outcomes studied with each additional unit of increase in particulate matter. Specifically, stroke rates increased by 2,536 for each additional ug/m3 (micrograms per cubic meter of air) increase in fine particulate matter each year.
- There was an increased risk of stroke and atrial fibrillation associated with long-term exposure to nitrogen dioxide.
- Pneumonia was the only health outcome in the study that seemed impacted by long-term exposure to ozone; however, researchers note there are currently no national guidelines denoting safe or unsafe long-term ozone levels.
“When we restricted our analyses to individuals who were only exposed to lower concentrations of air pollution, we still found increased risk of hospital admissions with all of the studied outcomes, even at concentration levels below current national standards,” added Danesh Yazdi. “More than half of the study population is exposed to low levels of these pollutants, according to U.S. benchmarks, therefore, the long-term health impact of these pollutants should be a serious concern for all, including policymakers, clinicians and patients.”
The researchers further stratified the analyses to calculate the cardiovascular and respiratory risks associated with each of the pollutants among patient subgroups including gender, race or ethnicity, age and socioeconomic factors, detailed in the study.
The causality in the study could only be interpreted and not proven definitively due to the limitations of the data available, which may have not included other known CVD risk factors. In addition, coding errors can occur in the Medicare database, which would impact the analyses.
Co-authors are Yan Wang, Ph.D.; Qian Di, Ph.D.; Yaguang Wei, Ph.D.; Weeberb J. Requia, Ph.D.; Liuhua Shi, Ph.D.; Matthew Benjamin Sabath, M.A.; Francesca Dominici, Ph.D.; Brent A. Coull, Ph.D.; John S. Evans, Ph.D.; Petros Koutrakis, Ph.D.; and Joel Schwartz, Ph.D. Author disclosures are listed in the manuscript.
The study was funded by grants from the National Institutes of Health/National Institute of Environmental Health Sciences and the United States Environmental Protection Agency.
Statements and conclusions of studies published in the American Heart Association’s scientific journals are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers are available here, and the Association’s overall financial information is available here.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org , Facebook , Twitter or by calling 1-800-AHA-USA1.
For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173
Michelle Kirkwood: 703-457-7838, firstname.lastname@example.org
For Public Inquiries: 1-800-AHA-USA1 (242-8721)